360o Virtual Tour360<sup>o</sup> Virtual Tour
Speak to Our Experts

2022

Aurigene Pharmaceutical Services, Launches its New Branding at CPhI North America

Aurigene has been established as a wholly-owned subsidiary of Dr. Reddy’s through the merger of Aurigene Discovery Services and Dr. Reddy’s Custom Pharma Services (CPS). The launch of the brand happened during the pandemic, and it is therefore the first opportunity for the team to exhibit the new brand to its customers.

Read More

2021

Aurigene Pharmaceutical Services Limited (APSL) invests in adding Large Molecule Discovery and Development Services

Aurigene Pharmaceutical Services Limited, a wholly-owned subsidiary of Dr. Reddy’s expands its existing discovery and development capacities with the inauguration of a biotherapeutics discovery facility in Hyderabad, India. Named New Biological Entity (NBE) Services, this .

Read More
DeepMatter to trial its DigitalGlassware® platform with Aurigene Pharmaceutical Services

DeepMatter Group Plc (AIM: DMTR, “Deepmatter”, the “Group”), the international digital chemistry data company, has signed a trials agreement with Aurigene Pharmaceutical Services Limited (“Aurigene Pharmaceutical Services”), based in Hyderabad, India, to supply its DigitalGlassware® platform.

Read More
x

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack